Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tunis Praises NEJM Editorial Calling On Doctors To Care About Societal Costs

This article was originally published in The Gray Sheet

Executive Summary

Physicians should take more responsibility for demonstrating cost-effectiveness of expensive therapies such as implantable cardioverter defibrillators, according to an editorial in the Dec. 9 issue of the New England Journal of Medicine

You may also be interested in...



Medtronic’s Stanton Stresses The Downsides Of Cost-Effectiveness Analyses

Cost-effectiveness analysis should not be included in Medicare coverage because the methodology is "too immature" and lacks a universal threshold for how much a quality life-year is worth, according to Medtronic Medical Director Marshall Stanton, MD

Medtronic’s Stanton Stresses The Downsides Of Cost-Effectiveness Analyses

Cost-effectiveness analysis should not be included in Medicare coverage because the methodology is "too immature" and lacks a universal threshold for how much a quality life-year is worth, according to Medtronic Medical Director Marshall Stanton, MD

National ICD Registry Proposal Critiqued By Manufacturers, ACC/HRS

CMS' implantable cardioverter defibrillator registry should limit its initial scope to follow-up data at the time of re-hospitalization to keep expenses manageable, according to ICD manufacturers and professional societies

Related Content

UsernamePublicRestriction

Register

MT021320

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel